Corrigendum

Teus MA, Miglior S, Laganovska G, et al.Efficacy and safety of travoprost/ timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2009;3:629-636.The footnote of Table 4 should read: DUOTRAV = Travoprost 40 ug/mL + Timolol 5 mg/mL eye&nbsp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Teus MA, Miglior S, Laganovska G, Volksone L, Romanowska-Dixon B, Gos R, Holló G; for the C-05-25 Study Group
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/8fa9576d26824485a29011ac5b7e3e5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Teus MA, Miglior S, Laganovska G, et al.Efficacy and safety of travoprost/ timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2009;3:629-636.The footnote of Table 4 should read: DUOTRAV = Travoprost 40 ug/mL + Timolol 5 mg/mL eye drops, solution. Cosopt = Dorzolamide 20 mg/mL + Timolol 5 mg/mL eye drops, solution. Estimates based on descriptive statistics.